REFERENCES
1. Marsella R. Calcineurin inhibitors: a novel approach to canine atopic dermatitis. J Am Anim Hosp Assoc 2005;41(2):92-97.
2. Robson D. Review of the properties and mechanisms of action of cyclosporine with an emphasis on dermatological therapy in
dogs, cats and people. Vet Rec 2003;152(25):768-772.
3. Brazis P, Barandica L, Garcia F, et al. Dermal microdialysis in the dog: in vivo assessment of the effect of cyclosporine
A on cutaneous histamine and prostaglandin D2 release. Vet Dermatol 2006;17(3):169-174.
4. Robson D. Review of the pharmacokinetics, interactions and adverse reactions of cyclosporine in people, dogs and cats. Vet Rec 2003;152(24):739-748.
5. Steffan J, Strehlau G, Maurer M, et al. Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis
in dogs. J Vet Pharmacol Ther 2004;27(4):231-238.
6. Robson DC, Burton GG. Cyclosporin: applications in small animal dermatology. Vet Dermatol 2003;14(1):1-9.
7. Bloom P. Symptomatic management of pruritus. In: Campbell KL ed. Small animal dermatology secrets. Philadelphia, Pa: Hanley & Belfus, imprint of Elsevier, 2004;53.
8. Radowicz SN, Power HT. Long-term use of cyclosporine in the treatment of canine atopic dermatitis. Vet Dermatol 2005;16(2):81-86.
9. Atopica [product insert]. New York, NY: Novartis Animal Health, 2007.
10. Parks SC. Observations on the incidence of cystitis in a population of dogs diagnosed with atopic dermatitis (poster). 18th Proc Am Acad Vet Dermatol Am Coll Vet Dermatol 2003;243.
11. Steffan J, Favrot C, Mueller R. A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment
of atopic dermatitis in dogs. Vet Dermatol 2006;17(1):3-16.
12. Steffan J, Alexander D, Brovedani F, et al. Comparison of cyclosporine A with methylprednisolone for treatment of canine
atopic dermatitis: a parallel, blinded, randomized, controlled trial. Vet Dermatol 2003;14(1):11-22.
13. Olivry T, Mueller RS, the International Task Force on Canine Atopic Dermatitis. Evidence-based veterinary dermatology: a
systematic review of the pharmacotherapy of canine atopic dermatitis. Vet Dermatol 2003;14(3):121-146.
14. Carothers MA, Kwochka KW, Rojko JL. Cyclosporine-responsive granulomatous sebaceous adenitis in a dog. J Am Vet Med Assoc 1991;198(9):1645-1648.
15. Linek M, Boss C, Haemmerling R, et al. Effects of cyclosporine A on clinical and histologic abnormalities in dogs with sebaceous
adenitis. J Am Vet Med Assoc 2005;226(1):59-64.
16. Noli C, Toma A. Three cases of immune-mediated adnexal skin disease treated with cyclosporin. Vet Dermatol 2006;17(1):85-92.
17. Mathews KA, Sukhiani HR. Randomized controlled trial of cyclosporine for treatment of perianal fistulas in dogs. J Am Vet Med Assoc 1997;211(10):1249-1253.
18. Mouatt JG. Cyclosporin and ketoconazole interaction for treatment of perianal fistulas in the dog. Aust Vet J 2002;80(4):207-211.
19. House AK, Guitian J, Gregory SP, et al. Evaluation of the effect of two dose rates of cyclosporine and the severity of perianal
fistulae lesions and associated clinical signs in dogs. Vet Surg 2006;35(6):543-549.
20. Hardie R, Bjorling D. University of Wisconsin School of Veterinary Medicine, Madison, Wis: Personal communication, 2007.
21. Last RD, Suzuki Y, Manning T, et al. A case of fatal systemic toxoplasmosis in a cat being treated with cyclosporin A for
feline atopy. Vet Dermatol 2004;15(3):194-198.
22. Callan MB, Preziosi D, Mauldin E. Multiple papillomavirus-associated epidermal hamartomas and squamous cell carcinomas in
situ in a dog following chronic treatment with prednisone and cyclosporine. Vet Dermatol 2005;16(5):338-345.
23. Werner AH Psoriasiform-lichenoid-like dermatosis in three dogs treated with microemulsified cyclosporine A. J Am Vet Med Assoc 2003;223(7):1013-1016.
|
Featuring Information from:
